Among critically ill adults with metabolic acidosis receiving vasopressors in the ICU, sodium bicarbonate did not lead to a lower risk of major adverse kidney events within 30 days than placebo. Full SODa-BIC trial results: https://nej.md/4ofXcyq
#CCR26 | @criticalcarereviews.com
Diabetes org apologizes for ejecting scientists over criticism of Trump arstechnica.com/health/2026/...
Two days later. @altmetric.com score nearly doubled. Upper bound reach around 5 mil BlueSky accounts and 1 mil Twitter accounts.
Again if you’d like to read the editorial is is available here:
diabetesjournals.org/care/article...
NEJM.org
17 days until retatrutide phase 3 data and here's some published and unpublished data on decreases in glucose, insulin resistance and fasting insulin levels in diabetics and non-diabetics. This just in obese patients and the decrease in fasting insulin is *enormous* over 50% and still dropping!
This is a crime.
www.nytimes.com/2026/05/05/u...
For days after the stunning incident, the ADA had doubled-down on the choice.
Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial.
Sometimes, "old" therapies are still valuable today.
www.nature.com/articles/s41...
@natmed.nature.com @escardio.bsky.social
#CardioSky #HeartFailure2026
I’ve officially resigned as Associate Editor for Frontiers in Systems Neuroscience. It used to be a reputable journal, but became a case study in how forced automation destroys academic integrity. 👇
I'll have A LOT of retatrutide thoughts. Alot. But these cardiometabolic improvements are stunning. 40% drop in triglycerides, 20% drop in LDL. 63% drop in hsCRP, 12 point reduction in BP. It's not a stretch to imagine this drug massively reducing death from CVD and CKD all on its own.
Cardiac resynchronization therapy restores ventricular synchrony in #HeartFailure patients with reduced ejection fraction and left bundle-branch block, improving function and lowering mortality. 🧵
ja.ma/4tTXfSR
